| http://www.w3.org/ns/prov#value | - Almost everyone involved benefits from a trial ending early -- doctors, researchers, funding sources, pharmaceutical firms, scientific journals, even reporters -- everyone except the patient, who may end up receiving a therapy on the basis of misleading information about its benefits.Our research shows that in most cases early stopping of clinical trials resulted in misleading estimates of treatm
|
